Author: insight

Montreal, November 19, 2018 – CQDM, Diazon and the Oncopole, in collaboration with Mitacs, are pleased to announce the creation of the Gordon Shore Prize to pay tribute to the remarkable accomplishments of Professor Shore in the field of cancer research. CQDM, Diazon, the Oncopole,...

Montreal, QC, November 16th 2016 – Diazon Pharmaceuticals Inc. today announced the publication of a preclinical oncology study identifying the novel mechanism of action of its new synthetic diazonamide compound, DZ-2384, in Science Translational Medicine. The results show that a distinct mode of binding to...

Wieczorek M, Tcherkezian J, Bernier C, Prota AE, Chaaban S, Rolland Y, Godbout C, Hancock M, Arezzo JC, Ocal O, Rocha C, Olieric N, Hall A, Ding H, Bramoullé A, Annis MG, Zogopoulos G, Harran PG, Wilkie TM, Brekken RA, Siegel PM, Steinmetz MO, Shore GC, Brouhard GJ, Roulston A.  The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity, Science Translational Medicine, 2016 Nov...